Yantacaw Capital
Venture fund · from SEC filings

MPM Bioventures 2018, L.P.

MPM BioImpact · adviser of record: MPM Asset Management LLC · 2017 vintage

MPM Bioventures 2018, L.P. is a 2017 venture fund managed by MPM BioImpact, with $400mm raised (Form D, amount sold). It reported $483mm in gross assets at year-end 2025, 1.21x its size, against a peak of $706mm in 2021.

Latest value held
$483mm year-end 2025
Peak
$706mm year-end 2021
Fund size
$400mm Form D, amount sold
Held vs. size
1.21x peak 1.77x

Value held by year-end

$200mm$400mm$600mm$800mm201720182019202020212022202320242025

Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker

Year-endGross assets÷ sizeChange
2025$483mm1.21x-26% over 2 yrs
2023$653mm1.63x-1%
2022$663mm1.66x-6%
2021$706mm1.77x+45%
2020$486mm1.22x+33%
2019$367mm0.92x+3%
2018$358mm0.89x+26%
2017$285mm0.71x–

Other funds from MPM BioImpact

All MPM BioImpact funds

About these numbers

Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-9483444745. Data updated October 13, 2026.

Is this your fund?

Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.